Chickpea (Cicer arietinum) and Other Plant-Derived Protease Inhibitor Concentrates Inhibit Breast and Prostate Cancer Cell Proliferation In Vitro

REFERENCES

• Mathers , J C . 2002 . Pulses and carcinogenesis: potential for the prevention of colon, breast and other cancers . Br J Nutr , 88 : S273 – S279 .
   PubMed Web of Science ®Google Scholar
• Schuurman , A G , Goldbohm , R A , Dorant , E and van den Brandt , P A . 1998 . Vegetable and fruit consumption and prostate cancer risk: a cohort study in the Netherlands . Cancer Epidemiol Biomarkers Prev , 7 : 673 – 380 .
   PubMed Web of Science ®Google Scholar
• Dong , J Y and Qin , L Q . 2011 . Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies . Breast Cancer Res Treat , 125 : 315 – 323 .
   PubMed Web of Science ®Google Scholar
• Jian , L . 2009 . Soy, isoflavones, and prostate cancer . Mol Nutr Food Res , 53 : 217 – 226 .
   PubMed Web of Science ®Google Scholar
• Chen , Y W , Huang , S C , Lin-Shiau , S Y and Lin , J K . 2005 . Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1 . Carcinogenesis , 26 : 1296 – 1306 .
   PubMed Web of Science ®Google Scholar
• McCormick , D L , Johnson , W D , Bosland , M C , Lubet , R A and Steele , V E . 2007 . Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor . Nutr Cancer , 57 : 184 – 193 .
   PubMed Web of Science ®Google Scholar
• Kennedy , A R . 1998 . Chemopreventive agents: protease inhibitors . Pharmacol Ther , 78 : 167 – 209 .
   PubMed Web of Science ®Google Scholar
• Kennedy , A R . 1998 . The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent . Am J Clin Nutr , 68 : 1406S – 1412S .
   PubMed Web of Science ®Google Scholar
• Grant , G , Dorard , P M , Buchan , W C , Armour , J C and Putztai , A . 1995 . Consumption of diets containing raw soya beans (Glycine max), kidney beans (Phaseolus vulgaris), cowpeas (Vigna-Unguiculata) or lupin seeds (Lupinus-Agustifolious) by rats for up to 700 days—effects on body composition and organ weights . Br J Nutr , 73 : 17 – 29 .
   PubMed Web of Science ®Google Scholar
• Friedman , M and Brandon , D L . 2001 . Nutritional and health benefits of soy proteins . J Agric Food Chem , 49 : 1069 – 1089 .
   PubMed Web of Science ®Google Scholar
• Zhang , L L , Wan , X S , Donahue , J J , Ware , J H and Kennedy , A R . 1999 . Effects of the Bowman-Birk inhibitor on cologenic survival and cisplatin or radiation induced cytotoxicity in human breast, cervical and head and neck cancer cells . Nutr Cancer , 33 : 165 – 173 .
   PubMed Web of Science ®Google Scholar
• Troll , W and Weisner , R . 1983 . Protease inhibitors: possible anti-carcinogens in edible seeds . Prostate , 4 : 345 – 349 .
   PubMed Web of Science ®Google Scholar
• Kennedy , A R and Wan , X S . 2002 . Effects of the Bowman-Birk inhibitor on growth, invasion and clonogenic survival of human prostate epithelial cells and prostate cancer cells . Prostate , 50 : 125 – 133 .
   PubMed Web of Science ®Google Scholar
• Tang , M , Asamoto , M , Ogawa , K , Naiki-Ito , A Sato , S . 2009 . Induction of apoptosis in the LNCaP human prostate carcinoma cell line and prostate adenocarcinomas of SV40T antigen transgenic rats by the Bowman-Birk inhibitor . Pathol Int , 59 : 790 – 796 .
   PubMed Web of Science ®Google Scholar
• Kennedy , A R , Billings , P C , Wan , X S and Newberne , P M . 2002 . Effects of Bowman-Birk inhibitor on rat colon carcinogenesis . Nutr Cancer , 43 : 174 – 186 .
   PubMed Web of Science ®Google Scholar
• Kennedy , A R , Beazer-Barclay , Y , Kinzler , K W and Newberne , P M . 1996 . Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor . Cancer Res , 56 : 679 – 682 .
   PubMed Web of Science ®Google Scholar
• Kennedy , A R , Szuhaj , B F , Newberne , P M and Billings , P C . 1993 . Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate . Nutr Cancer , 19 : 281 – 302 .
   PubMed Web of Science ®Google Scholar
• Malkowicz , S B , McKenna , W G , Vaughn , D J , Wan , X S Propert , K J . 2001 . Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia . Prostate , 48 : 16 – 28 .
   PubMed Web of Science ®Google Scholar
• Armstrong , W B , Kennedy , A R , Wan , X S , Taylor , T H Nguyen , Q A . 2000 . Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial . Clin Cancer Res , 6 : 4684 – 4691 .
   PubMed Web of Science ®Google Scholar
• Armstrong , W B , Kennedy , A R , Wan , X S , Atiba , J McLaren , C E . 2000 . Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia . Cancer Epidemiol Biomarkers Prev , 9 : 43 – 47 .
   PubMed Web of Science ®Google Scholar
• Lichtenstein , G R , Deren , J J , Katz , S , Lewis , J D Kennedy , A R . 2008 . Bowman-Birk inhibitor concentrate: a novel therapeutic agent for patients with active ulcerative colitis . Dig Dis Sci , 53 : 175 – 180 .
   PubMed Web of Science ®Google Scholar
• Yavelow , J , Caggana , M and Beck , K A . 1987 . Proteases occurring in the cell membrane: a possible cell receptor for the Bowman-Birk type protease inhibitors . Cancer Res , 47 : 1598 – 1601 .
   PubMed Web of Science ®Google Scholar
• Jin , X L , Hirosaki , T , Lin , C Y , Dickson , R B Higashi , S . 2005 . Production of soluble matriptase by human cancer cell lines and cell surface activation of its zymogen by trypsin . J Cell Biochem , 95 : 632 – 647 .
   PubMed Web of Science ®Google Scholar
• Forbs , D , Thiel , S , Stella , M C , Sturzebecher , A Schweinitz , A . 2005 . In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma . Int J Oncology , 27 : 1061 – 1071 .
   PubMed Web of Science ®Google Scholar
• Ware , J H , Wan , X S , Rubin , H , Schechter , N M and Kennedy , A R . 1997 . Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase . Arch Biochem Biophys , 344 : 133 – 138 .
   PubMed Web of Science ®Google Scholar
• Stephens , R W , Brunner , N , Janicke , F and Schmitt , M . 1998 . The urokinase plasminogen activator system as a target for prognostic studies in breast cancer . Breast Cancer Res Treat , 52 : 99 – 111 .
   PubMed Web of Science ®Google Scholar
• Rabbani , S A . 1998 . Metalloproteases and urokinase in angiogenesis and tumor progression . In Vivo , 12 : 135 – 142 .
   PubMed Web of Science ®Google Scholar
• Park , J H , Jeong , H J and de Lumen , B O . 2005 . Contents and bioactivities of lunasin, Bowman-Birk inhibitor, and isoflavones in soybean seed . J Agric Food Chem , 53 : 2686 – 7690 .
   Web of Science ®Google Scholar
• de Lumen , B O . 2005 . Lunasin: A cancer-preventive soy peptide . Nutrition Rev , 63 : 16 – 21 .
   PubMed Web of Science ®Google Scholar
• Frenkel , K , Chrzan , K , Ryan , C A , Weisner , R and Troll , W . 1987 . Chymotrypsin-specific protease inhibitors decrease H2O2 formation by activated human polymorphonuclear leukocytes . Carcinogenesis , 8 : 1207 – 1212 .
   PubMed Web of Science ®Google Scholar
• Tamir , S , Bell , J , Finlay , T H , Sakal , E Smirnoff , P . 1996 . Isolation, characterization, and properties of a trypsin-chymotrypsin inhibitor from amaranth seeds . J Protein Chem , 15 : 219 – 229 .
   PubMedGoogle Scholar
• Fernandes , A O and Banerji , A P . 1995 . Inhibition of benzopyrene-induced forestomach tumors by field bean protease inhibitor(s) . Carcinogenesis , 16 : 1843 – 1846 .
   PubMed Web of Science ®Google Scholar
• Clemente , A , Gee , J M , Johnson , I T , Mackenzie , D A and Domoney , C . 2005 . Pea (Pisum sativum L.) protease inhibitors from the Bowman-Birk class influence the growth of human colorectal adenocarcinoma HT29 cells in vitro . J Agric Food Chem , 53 : 8979 – 8986 .
   PubMed Web of Science ®Google Scholar
• Joanitti , G A , Azevedo , R B and Freitas , S M . 2010 . Apoptosis and lysosome membrane permeabilization induction on breast cancer cells by an anticarcinogenic Bowman-Birk protease inhibitor from Vigna unguiculata seeds . Cancer Lett , 293 : 73 – 81 .
   PubMed Web of Science ®Google Scholar
• Kassell , B . 1970 . Trypsin and chymotrypsin inhibitors from soybeans . Methods Enzymol , 19 : 853 – 852 .
   Google Scholar
• Rafiq , A and Bailey , G . 1998 . A more sensitive Hummel assay for chymotrypsin . Anal Biochem , 257 : 233 – 234 .
   PubMed Web of Science ®Google Scholar
• Brewer , J M , Robert , C W , Stimson , W H and Alexander , J . 1995 . Accurate determination of adjuvant-associated protein or peptide by Ninhydrin assay . Vaccine , 13 : 1441 – 1444 .
   PubMed Web of Science ®Google Scholar
• Soule , H , Vazquez , J , Long , A , Albert , S and Brennan , M . 1973 . A human cell line from a pleural effusion derived from a breast carcinoma . J Natl Cancer Inst , 51 : 1409 – 1416 .
   PubMed Web of Science ®Google Scholar
• Cailleau , R , Young , R , Olive , M and Reeves , W . 1974 . Breast tumour cell lines from pleural effusions . J Natl Cancer Inst , 53 : 661 – 674 .
   PubMed Web of Science ®Google Scholar
• Horoszewicz , J , Leong , S , Kawinski , E , Karr , J Rosenthal , H . 1983 . LNCaP model of human prostatic carcinoma . Cancer Res , 43 : 1809 – 1818 .
   PubMed Web of Science ®Google Scholar
• Kaighn , M , Shankar , N , Ohnuki , Y , Lechner , J and Jones , L . 1979 . Establishment and characterization of a human prostate carcinoma cell line (PC-3) . Invest Urol , 17 : 16 – 23 .
   PubMedGoogle Scholar
• Mosmann , T . 1983 . Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays . J Immunol Method , 65 : 55 – 63 .
   PubMed Web of Science ®Google Scholar
• Baldwin , E L and Osheroff , N . 2005 . Etoposide, topoisomerase II and cancer . Curr Med Chem , 5 : 363 – 372 .
   Google Scholar
• Ho , V SM and Ng , T B . 2008 . A Bowman-Birk trypsin inhibitor with antiproliferative activity from Hokkaido large black soybeans . J Pept Sc , 14 : 278 – 282 .
   PubMed Web of Science ®Google Scholar
• Hsieh , C C , Hernandez-Ledesma , B , Jeong , H J , Park , J H and de Lumen , B O . 2010 . Complementary roles in cancer prevention: Protease inhibitor makes the cancer preventive peptide lunasin bioavailable . PLoS One , 5 ( 1 ) : e8890 doi: 10.1371/journal.pone.0008890
   PubMed Web of Science ®Google Scholar
• Yavelow , J , Collins , M , Birk , Y , Troll , W and Kennedy , A R . 1985 . Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro . Proc Natl Acad Sci , 82 : 5395 – 5399 .
   PubMed Web of Science ®Google Scholar
• Giron-Calle , J , Vioque , J , del Mar Yust , M , Pedroche , J Alaiz , M . 2004 . Effect of chickpea aqueous extracts, organic extracts and protein concentrates on cell proliferation . J Med Food , 7 : 122 – 129 .
   PubMed Web of Science ®Google Scholar
• Kennedy , A R . 1994 . Prevention of carcinogenesis by protease inhibitors . Cancer Res , 54 : 1999S – 2005S .
   PubMed Web of Science ®Google Scholar
• Chang , J D , Li , J H , Billings , P C and Kennedy , A R . 1990 . Effects of protease inhibitors on c-myc expression in normal and transformed C3H 10T1/2 cell lines . Mol Carcinog , 3 : 226 – 232 .
   PubMed Web of Science ®Google Scholar
• Caggana , M and Kennedy , A R . 1989 . c-fos mRNA levels are reduced in the presence of antipain and Bowman-Birk inhibitor . Carcinogenesis , 10 : 2145 – 2148 .
   PubMed Web of Science ®Google Scholar
• Voorhees , P M , Dees , E C , O’Neil , B and Orlowski , R Z . 2003 . The proteasome as a target for cancer therapy . Clin Cancer Res , 9 : 6316 – 6325 .
   PubMed Web of Science ®Google Scholar
• Lam , Y , Galvez , A and de Lumen , B O . 2003 . Lunasin suppresses E1A-mediated transformation of mammalian cells but does not inhibit growth of immortalized and established cancer cell lines . Nutr Cancer , 47 : 88 – 94 .
   PubMed Web of Science ®Google Scholar
• Galvez , A F , Chen , N , Macasieb , J and de Lumen , B O . 2001 . Chemopreventive property of a soybean peptide (lunasin) that binds to deacetylated histones and inhibits acetylation . Cancer Res , 61 : 7473 – 7478 .
   PubMed Web of Science ®Google Scholar
• Jeong , H J , Lam , Y and de Lumen , B O . 2002 . Barley lunasin suppresses ras-induced colony formation and inhibits core histone acetylation in mammalian cells . J Agric Food Chem , 50 : 5903 – 5908 .
   PubMed Web of Science ®Google Scholar
• St Clair , W , Billings , P , Carew , J , Keller-McGandy , C Newberne , P . 1990 . Suppression of DMH-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor . Cancer Res , 50 : 580 – 586 .
   PubMed Web of Science ®Google Scholar